Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR

Pasireotide for the treatment of acromegaly

(2016) Luiz Eduardo Wildemberg et al.   EXPERT OPINION ON PHARMACOTHERAPY

Acromegaly: An Endocrine Society Clinical Practice Guideline

(2014) Laurence Katznelson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

(2014) A. Colao et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy

(2014) E. Ghigo et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Expert consensus document: A consensus on the medical treatment of acromegaly

(2014) Andrea Giustina et al.   Nature Reviews Endocrinology

Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study

(2014) Michael Sheppard et al.   Pituitary

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

(2014) Mônica R Gadelha et al.   Lancet Diabetes & Endocrinology

Management of hyperglycemia associated with pasireotide (SOM230): Healthy volunteer study

(2013) Astrid Breitschaft et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update

(2013) Laurence Katznelson et al.   Endocrine Practice

Effective Long-Term Treatment of Cushing's Disease with Pasireotide: A Case Report

(2013) Lin Lu et al.   Endocrine Practice

Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers

(2013) Robert R. Henry et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients

(2013) Orsalia Alexopoulou et al.   Pituitary

Pasireotide monotherapy in Cushing’s disease: a single-centre experience with 5-year extension of phase III Trial

(2013) Jessica MacKenzie Feder et al.   Pituitary

Managing hyperglycemia in patients with Cushing’s disease treated with pasireotide: medical expert recommendations

(2013) Annamaria Colao et al.   Pituitary

Management of hyperglycaemia in Cushing's disease: Experts’ proposals on the use of pasireotide

(2012) Y. Reznik et al.   DIABETES & METABOLISM

Metabolic Actions of Insulin-Like Growth Factor-I in Normal Physiology and Diabetes

(2012) David R. Clemmons   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Clinical Manifestations and Diagnosis of Acromegaly

(2012) Gloria Lugo et al.   International Journal of Endocrinology

Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues

(2011) Marinella Tzanela et al.   CLINICAL ENDOCRINOLOGY

Effects of somatostatin analogs on glucose homeostasis in rats

(2011) Herbert A Schmid et al.   JOURNAL OF ENDOCRINOLOGY

Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects

(2009) Niels Møller et al.   ENDOCRINE REVIEWS

Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies

(2009) Gherardo Mazziotti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Acromegaly

(2008) Anat Ben-Shlomo et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly

(2008) I M Holdaway et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY